Push for FDA approval of generic insulin continues
By
Haymarket Media
Jan 12, 2007
Experts say the cost of diabetes treatment could drop by 25% if the Food and Drug Administration approved the production and sale of generic insulin, according to a report in the New York Times.
Generics comprise growing percentage of Part D usage
By
Haymarket Media
Feb 12, 2007
About 60% of all prescription drugs used by beneficiaries in the Medicare Part D program through the third quarter of 2006 were generics, according to the Centers for Medicare & Medicaid Services.
PharMerica achieves 75% generic dispensing rate
Aug 04, 2010
PharMerica Corporation announced that the firm leads the long-term care pharmacy industry in generic medication dispensing, with a rate of over 75%. The company’s generic dispensing rate is on track...
The coronavirus likely began to spread worldwide last year, say researchers
By
Alicia Lasek
May 06, 2020
The pandemic may have started as early as October 2019, quickly adapting to its human host, according to a new genetic analysis.
Study: Wider generic use would save Part D program billions
By
Haymarket Media
Jan 25, 2007
Increasing the dispensing rates for generic drugs among Part D beneficiaries could save billions of dollars, a pharmaceutical industry study found.
Seniors should use generics to avoid “doughnut hole,” policymakers say
By
Haymarket Media
Sep 25, 2006
CMS Administrator Mark McClellan is urging greater use of generic drugs by Medicare prescription drug program beneficiaries to cut costs and improve access, he told the Senate Committee on Aging.
Generic drug use saves money in Part D program, studies find
By
Haymarket Media
Mar 06, 2006
Medicare beneficiaries who use generic medications in the new prescription drug plan can significantly cut costs, according to separate studies by the Consumers Union, and the Centers for Medicare & Medicaid.
Generic but not simple
By
John Hall
Oct 06, 2017
Pharmacists view new generics wave with caution, urge close look at regimens
Omnicare and McKesson expand agreement
Nov 25, 2014
Omnicare Inc. and McKesson Corporation have signed an expanded agreement to include the sourcing and distribution of branded, specialty and generic pharmaceuticals.
Monoclonal antibodies cut COVID-19 hospitalizations in high-risk adults: Mayo Clinic
By
Alicia Lasek
Jul 22, 2021
Patients treated early in the disease with either one of two antibody therapies had similarly low rates of hospitalization within 28 days.